Neuroendocrine Cancer UK - Not Just NE Cancer Podacast

Exploring Neuroendocrine Cancer Epidemiology with Prof. John Ramage

September 13, 2023 Neuroendocrine Cancer UK Season 2 Episode 7
Exploring Neuroendocrine Cancer Epidemiology with Prof. John Ramage
Neuroendocrine Cancer UK - Not Just NE Cancer Podacast
More Info
Neuroendocrine Cancer UK - Not Just NE Cancer Podacast
Exploring Neuroendocrine Cancer Epidemiology with Prof. John Ramage
Sep 13, 2023 Season 2 Episode 7
Neuroendocrine Cancer UK

In this episode, we have a fascinating conversation with Professor John Ramage, consultant physician in gastroenterology and hepatology at Hampshire Hospitals NHS Trust and Deputy Lead Clinician at King’s Health Partners NET Centre. Prof Ramage's research expertise lies in neuroendocrine tumours, where he investigates risk factors, epidemiology, and the quality of life for patients.

Our discussion revolves around epidemiology: what it is, why it's vital in recognising disease behaviour patterns, and how it's conducted. We dive into the sources of epidemiological data and explore how the outcomes of this research shape clinical practice. Discover how epidemiological research helps identify risk factors and gain insights into its future, including upcoming trials.

Further support:

Support the show

Show Notes

In this episode, we have a fascinating conversation with Professor John Ramage, consultant physician in gastroenterology and hepatology at Hampshire Hospitals NHS Trust and Deputy Lead Clinician at King’s Health Partners NET Centre. Prof Ramage's research expertise lies in neuroendocrine tumours, where he investigates risk factors, epidemiology, and the quality of life for patients.

Our discussion revolves around epidemiology: what it is, why it's vital in recognising disease behaviour patterns, and how it's conducted. We dive into the sources of epidemiological data and explore how the outcomes of this research shape clinical practice. Discover how epidemiological research helps identify risk factors and gain insights into its future, including upcoming trials.

Further support:

Support the show